X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (110) 110
child (98) 98
child, preschool (80) 80
male (78) 78
female (74) 74
infant (69) 69
oncology (61) 61
adolescent (48) 48
prognosis (48) 48
hematology (46) 46
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (46) 46
treatment outcome (40) 40
disease-free survival (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (36) 36
chemotherapy (28) 28
precursor cell lymphoblastic leukemia-lymphoma - mortality (28) 28
childhood (26) 26
acute lymphocytic-leukemia (24) 24
precursor cell lymphoblastic leukemia-lymphoma - genetics (24) 24
adult (23) 23
acute lymphoblastic leukemia (19) 19
remission induction (19) 19
risk factors (19) 19
therapy (19) 19
pediatrics (18) 18
precursor cell lymphoblastic leukemia-lymphoma - pathology (18) 18
risk (17) 17
children (16) 16
combined modality therapy (16) 16
intensive therapy (16) 16
survival analysis (16) 16
high-risk (15) 15
precursor cell lymphoblastic leukemia-lymphoma - therapy (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
pediatric-oncology-group (14) 14
recurrence (14) 14
survival rate (14) 14
cohort studies (13) 13
follow-up studies (13) 13
leukemia (13) 13
methotrexate - administration & dosage (13) 13
time factors (13) 13
age factors (12) 12
index medicus (12) 12
prednisone - administration & dosage (12) 12
vincristine - administration & dosage (12) 12
asparaginase - administration & dosage (11) 11
drug administration schedule (11) 11
immunophenotyping (11) 11
methotrexate (11) 11
retrospective studies (11) 11
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
clinical trials as topic (10) 10
injections, spinal (10) 10
relapse (10) 10
bone marrow transplantation (9) 9
cancer (9) 9
cranial irradiation (9) 9
daunorubicin - administration & dosage (9) 9
intensification (9) 9
leukocyte count (9) 9
life tables (9) 9
lymphoblastic leukemia in children (9) 9
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (9) 9
precursor cell lymphoblastic leukemia-lymphoma - radiotherapy (9) 9
survival (9) 9
age (8) 8
bone marrow - pathology (8) 8
chromosome aberrations (8) 8
clinical trials and observations (8) 8
cytarabine - administration & dosage (8) 8
karyotyping (8) 8
mercaptopurine - administration & dosage (8) 8
poor-prognosis (8) 8
presenting features (8) 8
translocation, genetic (8) 8
unfavorable presenting features (8) 8
antineoplastic agents - therapeutic use (7) 7
childrens cancer group (7) 7
cytogenetics (7) 7
event-free survival (7) 7
features (7) 7
follow-up (7) 7
gene (7) 7
infant, newborn (7) 7
leukemia, lymphoid - mortality (7) 7
philadelphia chromosome (7) 7
precursor cell lymphoblastic leukemia-lymphoma - complications (7) 7
prognostic factors (7) 7
acute lymphoblastic-leukemia (6) 6
all (6) 6
cancer group (6) 6
cancer-group (6) 6
cyclophosphamide - administration & dosage (6) 6
leukemia, lymphoid - therapy (6) 6
medicine, general & internal (6) 6
minimal residual disease (6) 6
multivariate analysis (6) 6
predictive value of tests (6) 6
prospective studies (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 906 - 915
Journal Article
Blood, ISSN 0006-4971, 02/2007, Volume 109, Issue 3, pp. 926 - 935
Journal Article
Blood, ISSN 0006-4971, 05/2003, Volume 101, Issue 10, pp. 3809 - 3817
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 02/2015, Volume 168, Issue 4, pp. 533 - 546
Children and adolescents presenting with a markedly elevated white blood cell (ME WBC) count (WBC 200x10(9)/l) comprise a unique subset of high-risk patients... 
SURVIVAL | INTENSIVE CHEMOTHERAPY | RISK | CLASSIFICATION | elevated white blood cell count | GROUP POG | CHILDHOOD | paediatric | UNFAVORABLE PRESENTING FEATURES | CANCER-GROUP | TRIAL | THERAPY | intensification | acute lymphoblastic leukaemia | HEMATOLOGY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Risk | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Dose-Response Relationship, Drug | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy | Vincristine - administration & dosage | Female | Idarubicin - administration & dosage | Leukemia, B-Cell - drug therapy | Leukocyte Count | Leukemia, B-Cell - mortality | Child | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Prednisone - administration & dosage | Kaplan-Meier Estimate | Leukocytosis - etiology | Treatment Outcome | Cranial Irradiation | Remission Induction | Asparaginase - administration & dosage | Leukemia, B-Cell - radiotherapy | Disease-Free Survival | Leukemia, B-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent
Journal Article
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 2/2010, Volume 24, Issue 2, pp. 285 - 297
The Children’s Cancer Group enrolled 13,298 young people age < 21 years on one of 16 protocols between 1983 and 2002. Outcomes were examined in three time... 
Acute lymphoblastic leukemia | children | randomized clinical trials
Journal Article
Journal Article